Patent ID: 9707173
Date: 2017-07-18
CPC Classifications: A61K,A61P

Claim:
1. A pharmaceutical suspension, comprising: an aqueous solution that includes high molecular weight polyethylene glycol, polyethylene oxide or both as a suspending agent, the high molecular weight polyethylene glycol, when included, having a molecular weight that is at least 2000; and a therapeutic agent that is suspended by the high molecular weight polyethylene glycol, polyethylene oxide or both within the solution wherein: i. the polyethylene oxide, when included in the suspension, is in the suspension at a concentration that is at least 0.5 w/v % but less that 10 w/v % and has a molecular weight of 100,000 to 8,000,000; and ii. the polyethylene glycol, when included in the suspension, is in the suspension at a concentration that is at least 15 w/v % but less that 50 w/v %.